ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685272 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685272; 2) Community: the network communities that were significantly associated with the response to NSC 685272; 3) Molecule: the relationships between components within communities and NSC 685272; 4) MDR: the compounds that were significantly associated with the NSC 685272.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0238174255956147 0.023941177
NSC 269760 B8 0.0238174255956147 0.51849416
NSC 300289 Pinafide 0.0238174255956147 -0.0050344153
NSC 303812 Aphidicoline glycinate 0.0238174255956147 -0.080180047
NSC 339137 PHYSALOLACTONE 0.0238174255956147 -0.10115
NSC 647763 Jasplakinolide epoxide C 0.0238174255956147 0.12385268
NSC 665514 Null 0.0238174255956147 0.042278776
NSC 673464 Null 0.0238174255956147 -0.052218588
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0238174255956147 -0.013922197
NSC 681633 Camptothecin Derivative 0.0238174255956147 0.20192035
Total:82  Current:36    [First] [Prev] [Next] [Last]